The early invasive strategy revisited: FRISC II at 5 years.

摘要

The merit of routine early invasive management versus non-invasive management for patients with acute coronary syndromes has been debated for over 15 years.This situation is not for want of data. During that time, more than 10000 such patients worldwide have been in randomised clinical trials. The absence of better outcomes in the TIMI IIIB and ICTUS trials, and the rather worse outcomes for invasive management in VANQWISH,3 are often cited to advocate a conservative or non-invasive approach to care